ReviewFrontiers in oncology2024

Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer.

Sanat Kulkarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.